Release Date: 17/01/14 08:56 Summary: Notice that defeating condition to takeover bid freed Price Sensitive: Yes Download Document 239.66KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%